Kristen Millado, M.D., joins Miami Cancer Institute as Medical Oncologist and Hematologist
MIAMI –September 30, 2021– Board-certified medical oncologist and hematologist Kristen Millado, M.D., joins Miami Cancer Institute, part of Baptist Health. Dr. Millado specializes in benign hematology and treating genitourinary cancers, including bladder, kidney, penile, prostate and testicular cancers. She is board-certified in internal medicine and board-eligible in hematology and oncology.
“Dr. Millado’s fellowship training and compassionate, multidisciplinary approach to treating genitourinary cancers and benign hematological disorders will make her an asset to Miami Cancer Institute,” said Leonard Kalman, M.D., executive deputy director and chief medical officer at Miami Cancer Institute. “We are pleased to welcome her to our team.”
Prior to joining Miami Cancer Institute, Dr. Millado completed a fellowship in hematology and oncology and was elected chief fellow at the Rush University Medical Center in Chicago.
She has served on the Governor’s Advisory Council for the American College of Physicians District of Columbia Chapter and as a member of hospital quality improvement and cancer committees.
Dr. Millado has been published in peer-reviewed journals, including the Journal of Clinical Oncology, the Journal of Urology and ASCO Daily News expert commentaries. She has also presented at national conferences, including the American College of Physicians National Conference and the San Antonio Breast Cancer Symposium.
Dr. Millado earned her medical degree from Michigan State University College of Human Medicine. She completed her residency in internal medicine at The George Washington University Hospital in Washington, D.C. This was followed by her medical oncology and hematology fellowship at the Rush University Medical Center.
She will see patients at the Baptist Health Wellness and Medical Complex in Plantation, located at 1228 S. Pine Island Road, Suite 410.
About Baptist Health South Florida
Baptist Health South Florida is the largest healthcare organization in the region, with 11 hospitals, more than 23,000 employees, 4,000 physicians and 100 outpatient centers, urgent care facilities and physician practices spanning across Miami-Dade, Monroe, Broward and Palm Beach counties. Baptist Health has internationally renowned centers of excellence in cancer, cardiovascular care, orthopedics and sports medicine, and neurosciences. In addition, it includes Baptist Health Medical Group; Baptist Health Quality Network; and Baptist Health Care On Demand, a virtual health platform. A not-for-profit organization supported by philanthropy and committed to its faith-based charitable mission of medical excellence, Baptist Health has been recognized by Fortune as one of the 100 Best Companies to Work For in America and by Ethisphere as one of the World’s Most Ethical Companies. For more information, visit BaptistHealth.net/Newsroom and connect with us on Facebook, Instagram, Twitter and LinkedIn.
About Miami Cancer Institute
Miami Cancer Institute brings to South Florida access to personalized clinical treatments and comprehensive support services delivered with unparalleled compassion. No other cancer program in the region has the combination of cancer-fighting expertise and advanced technology—including the first proton therapy center in South Florida, Latin America and the Caribbean, and one of the only radiation oncology program in the world with each of the newest radiation therapies in one place—to diagnose and deliver precise cancer treatments that achieve the best outcomes and improve the lives of cancer patients. The Institute offers an impressive roster of established community oncologists and renowned experts, clinical researchers and genomic scientists recruited from the nation’s top cancer centers. Selected as Florida’s only member of the Memorial Sloan Kettering Cancer (MSK) Alliance, Miami Cancer Institute is part of a meaningful clinical collaboration that affords patients in South Florida access to innovative treatments and ensures that the standards of care developed by their multidisciplinary disease management teams match those at MSK.
# # #